Extract from the Register of European Patents

EP About this file: EP2705868

EP2705868 - Dose counter for a metered-dose inhaler [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.08.2016
Database last updated on 08.04.2026
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Ivax International B.V.
Piet Heinkade 107
1019 GM Amsterdam / NL
[2015/44]
Former [2014/11]For all designated states
Ivax International B.v.
Computerweg 10
3542 DR Utrecht / NL
Inventor(s)01 / KAAR, Simon, G.
Cummeen
Donoughmore
Core / IE
02 / KARG, Jeffrey, A
2 Whitehall Lane
Hopkinton MA 01748 / US
03 / JOHNSON, Timothy, Norman
17 Christina Road
Raymond NH 03077 / US
04 / USCHOLD, Robert, Charles
236 Pierce Street
Leominster MA 01453 / US
 [2014/44]
Former [2014/15]01 / KAAR, Simon, G.
Cummeen
Donoughmore
Core / IE
Representative(s)Cottam, David William
Teva Global Patent Group
Field House Station Approach
Harlow Essex CM20 2FB / GB
[2014/11]
Application number, filing date13005367.128.07.2010
[2014/11]
Priority number, dateUS20090229830P30.07.2009         Original published format: US 229830 P
[2014/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2705868
Date:12.03.2014
Language:EN
[2014/11]
Type: B1 Patent specification 
No.:EP2705868
Date:21.10.2015
Language:EN
[2015/43]
Type: B8 Corrected title page of specification 
No.:EP2705868
Date:25.11.2015
[2015/48]
Search report(s)(Supplementary) European search report - dispatched on:EP07.02.2014
ClassificationIPC:A61M15/00, G06M1/04
[2014/11]
CPC:
A61M15/0078 (EP,US); A61M15/0071 (EP,US); A61M15/0076 (EP,US);
A61M15/009 (EP,US); G06M1/04 (EP,US); G06M1/083 (EP,US);
A61M15/0073 (US); A61M15/0075 (EP,US); A61M2202/064 (US);
G06M1/041 (US); G06M1/24 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/43]
Former [2014/11]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Dosiszähler für Inhalator mit abgemessener Dosis[2014/11]
English:Dose counter for a metered-dose inhaler[2014/11]
French:Compteur de doses pour inhalateur doseur[2014/11]
Examination procedure11.02.2014Examination requested  [2014/13]
21.08.2014Amendment by applicant (claims and/or description)
19.11.2014Despatch of a communication from the examining division (Time limit: M04)
26.02.2015Reply to a communication from the examining division
11.06.2015Communication of intention to grant the patent
10.09.2015Fee for grant paid
10.09.2015Fee for publishing/printing paid
10.09.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10744881.3  / EP2459258
Divisional application(s)EP15190668.2  / EP3031487
EP18193898.6
Opposition(s)22.07.2016No opposition filed within time limit [2016/39]
Fees paidRenewal fee
28.11.2013Renewal fee patent year 03
28.11.2013Renewal fee patent year 04
23.07.2014Renewal fee patent year 05
23.07.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL21.10.2015
BG21.10.2015
CY21.10.2015
EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
MK21.10.2015
RO21.10.2015
SI21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
[2018/46]
Former [2018/38]BG21.10.2015
CY21.10.2015
EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
MK21.10.2015
RO21.10.2015
SI21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2018/32]CY21.10.2015
EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
MK21.10.2015
RO21.10.2015
SI21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2018/29]CY21.10.2015
EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
MK21.10.2015
RO21.10.2015
SI21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/49]EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
RO21.10.2015
SI21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/38]EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
RO21.10.2015
SK21.10.2015
SM21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/36]EE21.10.2015
HR21.10.2015
LT21.10.2015
LV21.10.2015
RO21.10.2015
SK21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/25]HR21.10.2015
LT21.10.2015
LV21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/24]HR21.10.2015
LT21.10.2015
NO21.01.2016
GR22.01.2016
IS21.02.2016
PT22.02.2016
Former [2016/23]HR21.10.2015
LT21.10.2015
NO21.01.2016
IS21.02.2016
Former [2016/22]LT21.10.2015
NO21.01.2016
IS21.02.2016
Former [2016/21]LT21.10.2015
NO21.01.2016
Former [2016/20]LT21.10.2015
Documents cited:Search[XAI] WO9209324  (MINNESOTA MINING & MFG et al.)
 [A] GB2320489  (NORTON HEALTHCARE LTD et al.)
 [XAI] WO2008119552  (IVAX PHARMACEUTICALS IRELAND et al.) [X] 1-3,6,10,12,14,15 * page 1, lines 3-7; figures 1-11 * * page 4, line 36 - page 14, line 35 *[A] 4,5,8,13 [I] 7,9,11
 [A] US2008156321  (BOWMAN NICHOLAS et al.) [A] 1-15 * page 11, line 22 - page 17, line 16 *
ExaminationWO9856444
 WO2009041662
 EP2196234
 US2008035144
by applicantWO9828033
 WO9823033
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.